Monthly Archives: September 2013

What’s Behind The Booming Biotech IPO Market
September 23, 2013

Biotech is back with a vengeance in this IPO window.  After a decade drought, we’ve witnessed over 30 new biotech offerings this year and more than $2.5B raised – the best IPO market since 2000.  In fact, it’s already the


Winners’ Circle: New Insights Into BioPharma Venture Returns
September 17, 2013

Successful deals in venture capital take on a life of their own, especially the rare massive outlier return.  Unfortunately for venture capitalists, Facebooks and Twitters are very rare. Understanding the nature of “winners” requires a good grounding in what a


Ten Tips for Raising Startup Capital in Biotech
September 12, 2013

Summer is gone and the hectic autumn schedule is upon us (despite hitting 96F in Boston on Wednesday): back to the routine of board meetings, SABs, conferences, diligence sessions, and a ramped up travel schedule. Importantly, this also means that